Kisspeptin-10 Research Guide: Receptors, Evidence, and Lab Notes
Explore Hero kisspeptin-10, its KISS1R research background, distinctions from kisspeptin-54, evidence limits, and the exported 5 mg and 10 mg formats.
Quick facts
| Catalog name | Kisspeptin |
|---|---|
| Exported sizes | 5 mg and 10 mg |
| Research receptor | KISS1R, historically called GPR54 |
| Literature distinction | Kisspeptin-10 and kisspeptin-54 are different sequences |
| Confirmed fragment | Kisspeptin-10 |
| Hero product | Kisspeptin |
Kisspeptin-10 is a ten-residue member of the kisspeptin family. It appears alongside kisspeptin-54 in related research, but the two are different sequences. A useful laboratory guide keeps those identities separate and connects each finding to the fragment actually tested.
Hero’s kisspeptin research material is kisspeptin-10, listed in 5 mg and 10 mg formats in the supplied export. This guide explains its receptor biology, selected studies, and laboratory considerations. Exact terminal chemistry, chemical form, and lot properties still belong in the material specification.
Kisspeptin. View catalog product
Origin story: connecting KISS1 and GPR54
A 2001 primary paper identified kisspeptins encoded by the KiSS-1 gene as ligands for the receptor then called GPR54. This helped connect a peptide family with a defined receptor system. KISS1R is the receptor name used in current research terminology (Kotani et al., 2001).
The gene, precursor, processed fragments, and supplied laboratory sample should not be collapsed into one identity. A publication about gene expression does not automatically describe the properties of an isolated fragment. A fragment experiment should name the sequence tested.
The number after kisspeptin refers to chain length, not a vial size or strength ranking. A 10 mg container could hold a specified mass of one fragment or another. The mass does not identify which sequence is present.
How kisspeptin research works: target and pathway
KISS1R-related studies can examine receptor binding, signaling, or a later endocrine response. These are connected research layers, but each requires its own model and controls. A receptor response is not the same measurement as a circulating hormone concentration.
Animal research on kisspeptin-10 investigated hormone responses in adult male rats. Human research on kisspeptin-54 examined acute endocrine measurements in men. The fragment and model differ, so their findings should remain labeled accordingly (Thompson et al., 2004; Dhillo et al., 2005).
For a new experiment, specify whether the question concerns receptor activation or a downstream physiological system. The route from a target-level signal to an organism-level response includes additional variables that a simple binding experiment does not measure.
The GPCR explainer provides receptor background. It also helps distinguish a peptide’s interaction with a target from the wider interpretation of an experimental outcome.
Key studies: read the fragment beside the finding
| Study | Material and model | Research contribution | Boundary |
|---|---|---|---|
| Kotani et al., 2001 | Kisspeptin-family and receptor characterization | Ligand identification for GPR54 | Not an identity report for a supplied vial |
| Thompson et al., 2004 | Kisspeptin-10 in adult male rats | Endocrine measurements in an animal model | Not a human treatment study |
| Dhillo et al., 2005 | Kisspeptin-54 in men | Acute clinical endocrine investigation | Not direct evidence for an unspecified fragment or Hero lot |
A study involving one fragment can inform a question about another without answering it. Matching receptor activity in one assay does not independently establish matching exposure, duration, or downstream responses in another setting.
A helpful evidence table therefore includes fragment, species, preparation, comparator, and endpoint. This takes more effort than placing every result under kisspeptin, but it keeps the actual comparisons visible.
Read hormone measurements using their sampling context. A change at one time point and a pattern over time are different observations. Neither should be converted into a general promise about fertility, hormone optimization, or a supplied research material.
Weak spots: fragment identity is a prerequisite
Hero’s material is identified as kisspeptin-10. That fragment identity narrows the relevant literature, while the exact material form and preparation still need to match the experimental method. Findings for kisspeptin-54 should not be assigned to it without an appropriate comparison.
As of November 17, 2026, this guide does not establish an approved clinical use for Hero kisspeptin. Clinical observations involving a specified fragment do not authorize a separate supplier’s sample or establish its safety and effectiveness.
Exact terminal chemistry and chemical form also matter when comparing materials. A molecular-weight value drawn from a different fragment can make an apparently precise molarity calculation wrong. Confirm the appropriate lot specification before reporting that calculation.
Analytical identity, purity, net content, and receptor activity remain separate questions. A general purity percentage does not automatically establish the fragment sequence or quantify a functional response. Use documentation and tests suited to the property required.
Handling kisspeptin in the lab
The 5 mg and 10 mg formats describe nominal material mass. Select preparation conditions from the actual material specification and validated assay requirements. A method written for a different fragment is not automatically a preparation instruction for this sample.
For arithmetic only, nominal 5 mg at a final solution volume of 2 mL gives 2.5 mg/mL. Nominal 10 mg at the same final volume gives 5 mg/mL. These examples do not select a solvent, demonstrate compatibility, or establish a storage interval.
Mass-per-volume arithmetic and molarity are different calculations. Knowing the fragment name does not remove the need to use a molecular-weight basis appropriate to the supplied form. If the experiment needs a molar comparison, use the molecular-weight basis of the documented material, including relevant form and counterion information.
The calculator and mass-conversion guide support the arithmetic. The COA guide explains why a matching lot report is essential to a complete materials record.
Retain product ID, fragment identity, lot number, solvent, final volume, preparation date, and dilution history together. A future result is easier to interpret when those facts remain attached to the sample instead of being reconstructed from a product nickname.
Kisspeptin FAQ
Does kisspeptin-10 mean 10 mg?
No. The fragment name refers to ten amino-acid residues. A 10 mg label describes nominal material mass.
Are kisspeptin-10 and kisspeptin-54 interchangeable?
Not by assumption. They are different sequences, and results should remain attached to the fragment and model actually tested.
Which kisspeptin fragment does Hero supply?
Hero supplies kisspeptin-10. Its 5 mg and 10 mg options describe nominal material mass, while the 10 in the fragment name describes chain length.
What is Hero kisspeptin?
It is Hero’s kisspeptin-10 research material, listed in 5 mg and 10 mg formats. Consult the product and lot documentation for its precise supplied specifications and current availability.
Kisspeptin. View catalog product
References
- Kotani M, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631-34636. Source.
- Thompson EL, et al. Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol. 2004. Source.
- Dhillo WS, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. 2005. Source.
